|Systematic (IUPAC) name|
|(what is this?)|
Human and animal studies suggest that IC-26 is around the same potency as methadone, although other studies have found its activity to be inconsistent between different patients, with consistent opioid activity only being seen at a dose several times that of methadone. IC-26 was assessed for its abuse potential, but despite being found to have similar potential to methadone for development of dependence it was never placed under international control as an illegal drug.
- Tullar, B. F.; Wetterau, W.; Archer, S. (1948). "The Resolution of Ethyl 1,1-Diphenyl-3-dimethylaminobutyl Sulfone". Journal of the American Chemical Society 70 (11): 3959–3960. doi:10.1021/ja01191a532.
- US patent 2618640, Archer, S.; Suter, C. M.; Tullar, B. F., "Certain amino hydrocarbon sulfones and process of preparation", issued 1952-11-18, assigned to Sterling Drug
- Lednicer, D. (1982). Central Analgetics. p. 194. ISBN 0-471-08314-3.
- Janssen, P. A. J. (1960). "XVIII Sulphones". Diphenylpropylamines. Synthetic Analgesics 1. Pergamon Press. pp. 160–163. LCCN 59-13814.
- Wolbach, A. B.; Fraser, H. F. (1963). "Addiction Liability of I-C-26". Bulletin on Narcotics (UNODC) 1963 (1): 25–28.
|This analgesic-related article is a stub. You can help Wikipedia by expanding it.|